Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Akalin, Altuna Dr. (1) Costanza, Mariantonia Dr. (1) Daumke, Oliver Prof. Dr. (1) Franke, Vedran Dr. (1) Hinz, Michael Dr. (2) Hinze, Christian Dr. med. Dipl.-Math. (1) Hübner, Norbert Prof. Dr. (1) Janz, Martin Dr. (6) Kolesnichenko, Marina Dr. (1) Patone, Giannino Dr. (1) Scheidereit, Claus Prof. Dr. (5) Sczakiel, Henrike (1) Selbach, Matthias Prof. Dr. (1) (-) Mathas, Stephan Dr. (12) Bioinformatics and Omics Data Science (1) (-) Biologie maligner Lymphome (12) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Proteom Dynamik (1) Strukturbiologie Membran-assoziierter Prozesse (1) Systembiologie von Gen-regulatorischen Elementen (1) 1999 (1) 2000 (1) 2001 (1) (-) 2002 (5) 2003 (1) 2004 (2) 2005 (2) 2006 (4) 2007 (3) 2008 (4) 2009 (3) 2010 (3) (-) 2011 (4) 2012 (1) 2013 (1) 2014 (2) 2015 (5) 2016 (2) 2017 (3) (-) 2018 (1) (-) 2019 (2) 2020 (2) 2021 (3) 2022 (4) 2023 (8) 2024 (1) 12 Ergebnisse: Active Filter: Mathas, Stephan Dr.Biologie maligner Lymphome2002201120182019 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. April 2002 / Blood Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease F. Jundt K. Kley I. Anagnostopoulos K. Schulze-Proebsting A. Greiner S. Mathas C. Scheidereit T. Wirth H. Stein B. Doerken 01. Mai 2002 / Blood Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma F. Jundt I. Anagnostopoulos R. Foerster S. Mathas H. Stein B. Doerken 01. November 2002 / Blood In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp 130/STAT3 pathway M. Chatterjee D. Hoenemann S. Lentzsch K. Bommert C. Sers P. Herrmann S. Mathas B. Doerken R.C. Bargou 01. August 2002 / EMBO J Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B S. Mathas M. Hinz L. Anagnostopoulos D. Krappmann A. Lietz F. Jundt K. Bommert F. Mechta-Grigoriou H. Stein B. Dörken C. Scheidereit 14. April 2011 / Oncogene High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas K. Koechert K. Ullrich S. Kreher J.C. Aster M. Kitagawa K. Joehrens I. Anagnostopoulos F. Jundt B. Lamprecht U. Zimber-Strobl H. Stein M. Janz B. Doerken S. Mathas 02. September 2002 / J Exp Med Nuclear factor κB-dependent gene expression profiling of Hodgkins disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity M. Hinz P. Lemke I. Anagnostopoulos C. Hacker D. Krappmann S. Mathas B. Doerken M. Zenke H. Stein C. Scheidereit 14. Juli 2011 / Oncogene Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells U.M. Fagerli K. Ullrich T. Stuehmer T. Holien K. Koechert R.U. Holt O. Bruland M. Chatterjee H. Nogai G. Lenz J.D. Shaughnessy S. Mathas A. Sundan R.C. Bargou B. Doerken M. Borset M. Janz 01. November 2011 / Br J Haematol BAY 43-9006/Sorafenib blocks CSF1R activity and induces apoptosis in various classical Hodgkin lymphoma cell lines K. Ullrich K.D. Wurster B. Lamprecht K. Koechert A. Engert B. Doerken M. Janz S. Mathas 01. August 2011 / J Exp Med Genomic loss of the putative tumor suppressor gene E2A in human lymphoma A. Steininger M. Moebs R. Ullmann K. Koechert S. Kreher B. Lamprecht I. Anagnostopoulos M. Hummel J. Richter M. Beyer M. Janz C.D. Klemke H. Stein B. Doerken W. Sterry E. Schrock S. Mathas C. Assaf 01. September 2018 / Leukemia The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma N. Schleussner O. Merkel M. Costanza H.C. Liang F. Hummel C. Romagnani P. Durek I. Anagnostopoulos M. Hummel K. Jöhrens A. Niedobitek P.R. Griffin R. Piva H.L. Sczakiel W. Woessmann C. Damm-Welk C. Hinze D. Stoiber B. Gillissen S.D. Turner E. Kaergel L. von Hoff M. Grau G. Lenz B. Dörken C. Scheidereit L. Kenner M. Janz S. Mathas Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
15. April 2002 / Blood Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease F. Jundt K. Kley I. Anagnostopoulos K. Schulze-Proebsting A. Greiner S. Mathas C. Scheidereit T. Wirth H. Stein B. Doerken
01. Mai 2002 / Blood Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma F. Jundt I. Anagnostopoulos R. Foerster S. Mathas H. Stein B. Doerken
01. November 2002 / Blood In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp 130/STAT3 pathway M. Chatterjee D. Hoenemann S. Lentzsch K. Bommert C. Sers P. Herrmann S. Mathas B. Doerken R.C. Bargou
01. August 2002 / EMBO J Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B S. Mathas M. Hinz L. Anagnostopoulos D. Krappmann A. Lietz F. Jundt K. Bommert F. Mechta-Grigoriou H. Stein B. Dörken C. Scheidereit
14. April 2011 / Oncogene High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas K. Koechert K. Ullrich S. Kreher J.C. Aster M. Kitagawa K. Joehrens I. Anagnostopoulos F. Jundt B. Lamprecht U. Zimber-Strobl H. Stein M. Janz B. Doerken S. Mathas
02. September 2002 / J Exp Med Nuclear factor κB-dependent gene expression profiling of Hodgkins disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity M. Hinz P. Lemke I. Anagnostopoulos C. Hacker D. Krappmann S. Mathas B. Doerken M. Zenke H. Stein C. Scheidereit
14. Juli 2011 / Oncogene Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells U.M. Fagerli K. Ullrich T. Stuehmer T. Holien K. Koechert R.U. Holt O. Bruland M. Chatterjee H. Nogai G. Lenz J.D. Shaughnessy S. Mathas A. Sundan R.C. Bargou B. Doerken M. Borset M. Janz
01. November 2011 / Br J Haematol BAY 43-9006/Sorafenib blocks CSF1R activity and induces apoptosis in various classical Hodgkin lymphoma cell lines K. Ullrich K.D. Wurster B. Lamprecht K. Koechert A. Engert B. Doerken M. Janz S. Mathas
01. August 2011 / J Exp Med Genomic loss of the putative tumor suppressor gene E2A in human lymphoma A. Steininger M. Moebs R. Ullmann K. Koechert S. Kreher B. Lamprecht I. Anagnostopoulos M. Hummel J. Richter M. Beyer M. Janz C.D. Klemke H. Stein B. Doerken W. Sterry E. Schrock S. Mathas C. Assaf
01. September 2018 / Leukemia The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma N. Schleussner O. Merkel M. Costanza H.C. Liang F. Hummel C. Romagnani P. Durek I. Anagnostopoulos M. Hummel K. Jöhrens A. Niedobitek P.R. Griffin R. Piva H.L. Sczakiel W. Woessmann C. Damm-Welk C. Hinze D. Stoiber B. Gillissen S.D. Turner E. Kaergel L. von Hoff M. Grau G. Lenz B. Dörken C. Scheidereit L. Kenner M. Janz S. Mathas